A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: distribute (102), allot (2)

1607TalimogeneRx108PFU (2)

Description
TALIMOGENE 108PFU/ml for MELANOMA INITIAL PRESCRIPTION – Second and Subsequent ADMINISTRATIONS ONLY Please Attach Addressograph Patient Information Card Yes / No (please
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx108PFU-2.pdf

1607TalimogeneRx106PFU (2)

Description
TALIMOGENE 106 PFU/ml for MELANOMA INITIAL PRESCRIPTION – FIRST ADMINISTRATION ONLY Please Attach Addressograph Patient Information Card Yes / No (please circle
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/1607TalimogeneRx106PFU-2.pdf

Temporary changes to outpatient pharmacy

Description
The outpatient pharmacy at Southampton General Hospital is undergoing a redesign, with work starting on Saturday, 17 August. This essential work
Url
/AboutTheTrust/Newsandpublications/Latestnews/2019/August/Temporary-changes-to-outpatient-pharmacy.aspx

Ibrutinib (MCL) (560mg)

Description
Chemotherapy Protocol Mantle Cell Lymphoma Regimen Ibrutinib • MCL – Ibrutinib (560mg) Indication • Mantle Cell Lymphoma with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-MCL-560mg.pdf

Cyclophosphamide (PO)-Fluorouracil-Methotrexate (CMF PO)

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE (PO)-FLUOROURACIL-METHOTREXATE (CMF-PO) Regimen • Breast Cancer – Cyclopho
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CyclophosphamideFluorouracilMethotrexateCMF-PO.pdf

SOP setting up a new trial in shared care centre - 1 February 2013

Description
Paediatric Oncology UHSStandard Operating ProcedureOpening a New Trial in an Shared Care Centre (POSCU)SOP Number: Version Number and Date:PB_TRIAL
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/POSCU/SOP-Setting-up-a-new-trial-in-shared-care-centre-01-02-2013.pdf

Papers Trust Board - 11 November 2025

Description
Date Time Location Chair Agenda Trust Board – Open Session 11/11/2025 9:00 - 13:00 Conference Room, Heartbeat Education Centre
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-11-November-2025.pdf

Vismodegib

Description
Chemotherapy Protocol BASAL CELL CARCINOMA (BCC) VISMODEGIB Regimen  BCC - Vismodegib Indication  The patient either has; a. Gorlin Syndrome with non-locally
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Vismodegib.pdf

Capecitabine-Oxaliplatin 4-cycles

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and OXALIPLATIN (CAPOX-4 cycles) Regimen • Colorectal Cancer – Capecitabine-Oxaliplatin 4 cyc
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Oxaliplatin-4-cycles.pdf

Pertuzumab/Trastuzumab SC

Description
Chemotherapy Protocol BREAST CANCER Regimen Pertuzumab / Trastuzumab SC • Breast Cancer – Trastuzumab / Pertuzumab SC Indication • Treatment of early breast cancer (EBC) in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/PertuzumabTrastuzumab-SC.pdf
71 to 80 of 181
Previous … 6 7 8 9 10 … Next